Welcome to Skilled in the Art. I’m Law.com IP reporter Scott Graham. Today I’ve got a look at the Patent Trial and Appeal Board’s and Federal Circuit’s fast response to the Supreme Court’s SAS Institute decision, along with a couple of gray areas still being fleshed out. Also, AbbVie‘s patent battle with Boehringer Ingelheim just got really interesting, and Cisco Systems is trying to put an exclamation point on Oracle v. Google. Lend me an ear and email me your feedback. Or follow me on Twitter. 

➤➤ Would you like to receive Skilled in the Art as an email? Sign up here.


This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]